Centene Corporation (CNC) Business Profile

What it does

Centene Corporation is a managed-care company that arranges and pays for healthcare coverage, rather than delivering most care itself. Founded in 1984 and headquartered in St. Louis, it serves people covered by public health programs and individual health insurance, with a focus on underserved populations.

Its Medicaid plans serve low-income families, children, people with disabilities, older adults needing long-term services, people in foster care and people eligible for both Medicaid and Medicare. Its Medicare business offers Medicare Advantage plans, plans for dual-eligible members, Medicare Supplement coverage and stand-alone Medicare Part D prescription-drug plans. Its Commercial segment sells Ambetter Health Marketplace coverage and certain individual, group, off-exchange and ICHRA-compatible plans.

Centene builds networks of physicians, hospitals, behavioral-health practitioners, pharmacies and other providers. Members generally use those networks for care, while Centene administers eligibility, claims, care management, provider contracting, pharmacy oversight and customer service. Its state-based plans use local brands and teams, while centralized operations provide shared technology, finance, compliance and administrative services.

Its Other segment includes AcariaHealth specialty pharmacy services, vision and dental benefits, clinical healthcare operations in Florida and outpatient primary and behavioral healthcare through Denova Collaborative Health. Centene has also signed an agreement to divest its remaining Magellan Health businesses.

How it makes money

Centene receives premiums and service revenue for administering health benefits. In Medicaid, states administer programs and contract with managed-care organizations; Centene seeks to match state premium rates to members’ medical needs and utilization. Medicare Advantage plans generally receive a fixed monthly payment per member from CMS, with payments varying by county, demographics and health status. Its PDP business receives Medicare Part D-related payments and operates within federal risk-sharing arrangements for drug costs. Marketplace and other commercial plans collect premiums, including coverage supported by advance premium tax credits for eligible enrollees.

The company retains the difference between revenue and the cost of members’ healthcare, administration and services. Its principal operating measure is the health benefits ratio, medical costs as a percentage of premium revenue excluding separately billed premium taxes. Its SG&A ratio measures selling, general and administrative costs as a percentage of premium and service revenue, also excluding separately billed premium taxes. Medical costs tend to rise later in the year for Medicare Advantage and commercial members as deductibles and out-of-pocket maximums are reached.

Medicaid was 57% of FY2025 external revenue, Commercial 21%, Medicare 19% and Other 3%. Medicaid, Medicare and Marketplace coverage are generally administered under regulated government programs, and Medicare Advantage and PDP contracts are renewed on successive one-year terms unless non-renewed.

For the year ended December 31, 2025, total revenue was $194.8 billion; Q2 2026 premium and service revenue was $44.4 billion.

Customers and how it sells

Centene’s customers include state Medicaid agencies, CMS and Medicare beneficiaries, individuals and families buying Marketplace coverage, employers using certain commercial or ICHRA arrangements, and members of employer and union Medicare plans. It also serves providers and government partners through contracts and care-management programs.

As of December 31, 2025, Centene had 27.6 million members. It served 12.5 million Medicaid members in 30 states, 5.5 million Marketplace members in 29 states, 1.0 million Medicare Advantage members in 32 states, and 8.1 million PDP members in 50 states and the District of Columbia. Marketplace coverage is sold under the Ambetter Health brand, while Medicare Advantage is primarily offered under Wellcare. The PDP offering uses a national in-network prescription-drug coverage model.

Florida and New York each accounted for approximately 10% or more of consolidated Medicaid premium revenue in 2025. State rules determine eligibility, covered benefits, payment rates and program administration, so Centene operates through local health plans and state-specific provider networks.

Centene had roughly 3.5 million Marketplace members at the end of Q2 2026 and expects membership to decline through the remainder of 2026 as regular seasonality and program-integrity efforts affect enrollment.

Suppliers and costs

Centene’s care-delivery inputs are healthcare services and drugs purchased through contracted provider and pharmacy networks. It contracts with primary-care and specialty physicians, hospitals, behavioral-health practitioners and ancillary providers, typically using negotiated fee arrangements. Primary-care networks are important to care delivery, affordability and member retention.

Medical benefits are the principal cost category. During 2025, Centene experienced faster medical-cost trend from increased medical demand, expanded access to care and new high-cost pharmaceuticals. In Q2 2026, management identified behavioral health, home health and high-cost drugs as leading Medicaid cost drivers. The company uses care management, network design, fraud, waste and abuse initiatives, data analysis and provider value-based arrangements to manage costs.

Pharmacy is a material purchasing area. Management said Centene has greater than $60 billion in pharmacy spend through its partnership with ESI. Administrative costs include personnel, claims processing, information technology, member services, compliance, provider contracting, finance and other centralized functions. Centene had 61,100 employees in FY2025.

Competitive position

Centene competes for state, county, federal and commercial contracts with managed-care organizations, specialty providers and emerging non-traditional entrants. It also competes to enroll and retain members, and to maintain provider networks. Government agencies assess quality of care, provider access, administrative efficiency, financial strength, prior performance and local investment when awarding contracts. Members commonly evaluate health plans on care quality, provider inclusion, access, supplemental benefits and plan pricing. Providers consider membership volume, reimbursement, value-based payment experience, payment speed and administrative support.

Centene does not identify individual competing companies by name. The identity and importance of competitors vary by geography and product line.

Our reading: Centene’s scale in Medicaid, Marketplace and stand-alone PDP coverage is a meaningful operating advantage because those markets require broad member, provider and administrative capabilities; its strength depends on retaining contracts and networks.

Our reading: Its local-plan model and relationships with states, providers and community organizations are a meaningful source of differentiation where state-level execution and local access affect contract awards and member experience.

Our reading: Data, care-management programs and centralized services can support cost and quality management, but they are not exclusive barriers because competing plans can invest in similar capabilities.

Growth opportunities

Centene’s growth opportunities are tied to government-sponsored coverage, Medicare integration and individual insurance. The company sees Medicaid managed care as an opportunity as states seek to coordinate care and control costs for low-income, disabled and long-term-care populations. It served 12.5 million Medicaid members at year-end 2025, while states may also move specialty populations into managed care through contract-request cycles.

In Medicare, Centene is refining its footprint to overlap more closely with Medicaid and offer D-SNP plans for people eligible for both programs. The company notes that more than 70% of approximately 12 million fully eligible dual beneficiaries are not in integrated-care plans. CMS rules will require certain beneficiaries enrolled in both Medicare and Medicaid managed care to receive integrated care through the Medicaid company’s Medicare Advantage D-SNPs beginning in 2030, with some restrictions beginning in 2027. Centene plans to simplify its Medicare Advantage footprint in 2027 and focus benefits increasingly on dual-eligible members.

Marketplace growth depends on enrollment, plan pricing and subsidy rules. Centene expects 2026 Marketplace membership to decline as enhanced subsidies have expired and eligibility rules change, but management describes the individual market as a platform for individuals, small-business owners and portable coverage. Its ICHRA offering operated in 13 states in 2026; management said it had roughly 50,000 members in Q2 2026.

Centene expects full-year 2026 adjusted diluted earnings per share of greater than $4.80, following stronger Marketplace and PDP margin expectations.

Structural risks

• Medical costs and rates. Centene’s results can be adversely affected if it does not identify medical-cost trends promptly or if state and other rates do not adequately reflect rising acuity. Behavioral health, home health and high-cost drugs were significant cost drivers in 2026.
• Medicaid eligibility and funding. Reductions or delays in program funding, eligibility changes and state implementation of OBBBA requirements can reduce membership, change member acuity and alter benefits or provider-payment rates.
• Marketplace policy and enrollment. The expiry of enhanced subsidies, Marketplace integrity rules, eligibility verification and litigation can reduce membership and raise morbidity among remaining enrollees.
• Medicare Part D and Medicare Advantage rules. Part D benefit redesign shifts cost-sharing responsibilities and federal risk-sharing terms. Medicare Advantage results also face medical-cost pressure and uncertainty around Stars methodology and cut points.
• Contract, regulatory and compliance exposure. The business is regulated by federal, state and local agencies, and its health plans require licenses, capital, reporting, provider networks and regulatory approval for certain changes. Contract awards and renewals depend on performance and compliance.
• Execution, technology and transactions. Competition, provider consolidation, new entrants, artificial intelligence developments, data-security obligations and the pending divestiture of remaining Magellan Health businesses can affect operations and results.

Bottom line

Our reading

Our reading: Centene is a large, regulated managed-care operator whose revenue is principally tied to Medicaid, Medicare and Marketplace enrollment, government payment rules and its ability to keep medical costs aligned with rates. Its local state-plan model, broad membership and provider networks support its position, while also making results sensitive to state decisions and contract execution. The main operating question is whether rate actions, care management and administrative efficiencies can offset medical-cost trend and eligibility-driven membership changes. Its Medicare dual-eligible strategy and ICHRA offering add longer-term avenues beyond core Medicaid.